TO THE EDITOR,
In 2010 we reported two separate homozygous mutations in the 5' region of JUP which segregated with skin fragility and normal heart development in children from four separate families (1) . At the time, only 3 mutations in this gene had been previously reported and each of the earlier identified mutations segregated with an inherited progressive disease of the heart, arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C)(2-4). Five years on and as a result of close monitoring in each patient we report here that the eldest individual harboring homozygous mutations p.S24X has been diagnosed with left dilated cardiomyopathy (also considered ARVD/C) at age 17 years. All other patients examined report normal heart function.
The JUP gene encodes the protein plakoglobin (PG), also known as -catenin, which is abundant in cell cell junction complexes of adherens junctions and desmosomes. As well as this structural role PG can also influence cellular signaling where it's homology to and interaction with, -catenin is crucial (for review see (5)). Mutations in JUP leading to Naxos disease(3), a so-called cardio-cutaneous syndrome affecting both skin and heart, identified PG as a protein important in these tissues, and confirmed earlier observations that mutation in genes encoding desmosomal components are a major cause of this type of cardiomyopathy (6) . While originally termed ARVD/C, it has been shown that both right and left ventricles are often affected and as such, a
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This article is protected by copyright. All rights reserved. descriptive change to Arrhythmogenic Cardiomyopathy (AC) has been proposed to better reflect the pathology (7) . Nearly half of all diagnosed AC patients harbor mutation in at least one of the genes encoding desmosomal proteins expressed in the heart: PG (JUP), plakophilin2 (PKP2), desmoplakin (DSP), desmocollin2 (DSC2), and desmoglein2 (DSG2). Thus, AC is classified as a disease of the desmosome. The majority of desmosomal gene mutations (48.1%) have been identified in PKP2 (8) while JUP represents the least affected, contributing to 3.8% of all mutations(9) (see Table 1 and Fig. 1 for a summary of pathogenic JUP mutations) .
Prompted by the observation that since our publication 10 further mutations have been reported in JUP and that all of these mutations, with the except of p.Q539X which resulted in early lethality due to severe skin involvement (10) , are associated with AC(9), we re-visited the hospital records of patients harboring p.S24X and the splice site mutation, c.468G>A. Informed consent and ethical approval to study molecular and skin pathology in these children were obtained for the original study (1) , while here we report clinical follow-up. These five patients are monitored regularly (every 2-3 years) and records showed that the eldest patient harboring p.S24X presented with slight dilation of the left ventricle with normal systolic function as determined by Doppler echocardiography at age 17 ( Table 2 ). The cardiac involvement progressed to diagnosis of left dilated cardiomyopathy 20 months later, age 19, at which point the patient was prescribed angiotensin-converting enzyme inhibitors and -blockers. Further monitoring will determine whether an implantable cardioverter-defibrillator (ICD) is necessary (11) . Given the development of heart involvement we propose to reclassify patients harboring p.S24X mutation in JUP as a cardio-cutaneous syndrome.
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Since our original report the two patients harboring c.468G>A mutation in JUP have two new siblings affected by the same disorder. All four individuals share phenotypic characteristics which include: diffuse hypotrichosis, diffuse palmoplantar keratoderma (observed to worsen with advancing age), recurrent paronychia followed by nail-dystrophy; skin fragility; eczematoid skin rashes affecting mainly the scalp, face & extremities; poor dentition; and recurrent skin infections. As previously reported the most notable difference with patients harboring p.S24X JUP mutation is the presence of hypotrichosis (1) (Figure 2 ). Given the structural and ultrastructural similarities we previously reported between patients harboring homozygous p.S24X and c.468G>A mutations(1), we predict that patients with c.468G>A will likely develop similar cardiac abnormalities. All patients will continue to be monitored on a regular basis.
